CA2566645A1 - Prothese d'unite rachidienne fonctionnelle - Google Patents

Prothese d'unite rachidienne fonctionnelle Download PDF

Info

Publication number: CA2566645A1
Authority: CA; Canada
Prior art keywords: facet joint; component; fastener; facet; ligament
Prior art date: 2004-05-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002566645A

Other languages

English (en)

Inventor

Hassan A. Serhan

Robert Labrom

John Riley Hawkins

William Dunbar

Amie Borgstrom

Seungkyu Daniel Kwak

Andrew Dooris

Michael A. Slivka

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

DePuy Spine LLC

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-20

Filing date

2005-05-18

Publication date

2005-12-01

2004-05-20 Priority claimed from US10/850,280 external-priority patent/US20050055096A1/en

2005-05-18 Application filed by Individual filed Critical Individual

2005-12-01 Publication of CA2566645A1 publication Critical patent/CA2566645A1/fr

Status Abandoned legal-status Critical Current

Links

210000002517 zygapophyseal joint Anatomy 0.000 claims abstract description 173
210000003041 ligament Anatomy 0.000 claims description 145
210000000988 bone and bone Anatomy 0.000 claims description 44
238000000034 method Methods 0.000 claims description 42
230000033001 locomotion Effects 0.000 claims description 38
239000000463 material Substances 0.000 claims description 25
238000003780 insertion Methods 0.000 claims description 9
230000037431 insertion Effects 0.000 claims description 9
230000003416 augmentation Effects 0.000 claims description 6
238000002560 therapeutic procedure Methods 0.000 claims description 5
230000008569 process Effects 0.000 description 29
239000002775 capsule Substances 0.000 description 14
230000006870 function Effects 0.000 description 12
238000004873 anchoring Methods 0.000 description 9
230000004927 fusion Effects 0.000 description 8
239000003102 growth factor Substances 0.000 description 8
-1 titanium Chemical class 0.000 description 8
238000000576 coating method Methods 0.000 description 7
210000004027 cell Anatomy 0.000 description 6
239000011248 coating agent Substances 0.000 description 6
229920000642 polymer Polymers 0.000 description 6
230000008901 benefit Effects 0.000 description 5
238000013461 design Methods 0.000 description 5
239000000835 fiber Substances 0.000 description 5
210000004749 ligamentum flavum Anatomy 0.000 description 5
230000000278 osteoconductive effect Effects 0.000 description 5
238000005452 bending Methods 0.000 description 4
230000007423 decrease Effects 0.000 description 4
239000004744 fabric Substances 0.000 description 4
239000000017 hydrogel Substances 0.000 description 4
239000007943 implant Substances 0.000 description 4
238000002513 implantation Methods 0.000 description 4
239000002184 metal Substances 0.000 description 4
229910052751 metal Inorganic materials 0.000 description 4
229920000728 polyester Polymers 0.000 description 4
229920002635 polyurethane Polymers 0.000 description 4
239000004814 polyurethane Substances 0.000 description 4
238000001356 surgical procedure Methods 0.000 description 4
210000001519 tissue Anatomy 0.000 description 4
229920000954 Polyglycolide Polymers 0.000 description 3
102000004887 Transforming Growth Factor beta Human genes 0.000 description 3
108090001012 Transforming Growth Factor beta Proteins 0.000 description 3
239000002253 acid Substances 0.000 description 3
238000013459 approach Methods 0.000 description 3
230000002146 bilateral effect Effects 0.000 description 3
210000001185 bone marrow Anatomy 0.000 description 3
210000004271 bone marrow stromal cell Anatomy 0.000 description 3
230000006835 compression Effects 0.000 description 3
238000007906 compression Methods 0.000 description 3
230000006378 damage Effects 0.000 description 3
229920001971 elastomer Polymers 0.000 description 3
239000012530 fluid Substances 0.000 description 3
238000002684 laminectomy Methods 0.000 description 3
230000007774 longterm Effects 0.000 description 3
230000013011 mating Effects 0.000 description 3
210000002901 mesenchymal stem cell Anatomy 0.000 description 3
150000002739 metals Chemical class 0.000 description 3
239000004633 polyglycolic acid Substances 0.000 description 3
229920001343 polytetrafluoroethylene Polymers 0.000 description 3
239000004810 polytetrafluoroethylene Substances 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
108090000623 proteins and genes Proteins 0.000 description 3
238000002271 resection Methods 0.000 description 3
210000004872 soft tissue Anatomy 0.000 description 3
230000000087 stabilizing effect Effects 0.000 description 3
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 3
SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
229920000049 Carbon (fiber) Polymers 0.000 description 2
229920004934 Dacron® Polymers 0.000 description 2
UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 description 2
108010090254 Growth Differentiation Factor 5 Proteins 0.000 description 2
102100035379 Growth/differentiation factor 5 Human genes 0.000 description 2
208000031481 Pathologic Constriction Diseases 0.000 description 2
239000004698 Polyethylene Substances 0.000 description 2
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
101100472152 Trypanosoma brucei brucei (strain 927/4 GUTat10.1) REL1 gene Proteins 0.000 description 2
206010052428 Wound Diseases 0.000 description 2
208000027418 Wounds and injury Diseases 0.000 description 2
229960002684 aminocaproic acid Drugs 0.000 description 2
230000002917 arthritic effect Effects 0.000 description 2
239000004917 carbon fiber Substances 0.000 description 2
210000000845 cartilage Anatomy 0.000 description 2
239000000919 ceramic Substances 0.000 description 2
229920001577 copolymer Polymers 0.000 description 2
238000006073 displacement reaction Methods 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000009093 first-line therapy Methods 0.000 description 2
239000011521 glass Substances 0.000 description 2
239000003292 glue Substances 0.000 description 2
229910052588 hydroxylapatite Inorganic materials 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
210000004446 longitudinal ligament Anatomy 0.000 description 2
239000000314 lubricant Substances 0.000 description 2
VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
239000000203 mixture Substances 0.000 description 2
BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
230000003349 osteoarthritic effect Effects 0.000 description 2
230000007170 pathology Effects 0.000 description 2
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
239000004033 plastic Substances 0.000 description 2
229920000573 polyethylene Polymers 0.000 description 2
239000005020 polyethylene terephthalate Substances 0.000 description 2
229920000098 polyolefin Polymers 0.000 description 2
229920001296 polysiloxane Polymers 0.000 description 2
230000002980 postoperative effect Effects 0.000 description 2
239000005060 rubber Substances 0.000 description 2
230000036262 stenosis Effects 0.000 description 2
208000037804 stenosis Diseases 0.000 description 2
229940124597 therapeutic agent Drugs 0.000 description 2
239000010936 titanium Substances 0.000 description 2
229910052719 titanium Inorganic materials 0.000 description 2
238000011282 treatment Methods 0.000 description 2
230000010415 tropism Effects 0.000 description 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 1
TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 description 1
LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
229910000851 Alloy steel Inorganic materials 0.000 description 1
208000030016 Avascular necrosis Diseases 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
206010061246 Intervertebral disc degeneration Diseases 0.000 description 1
208000012659 Joint disease Diseases 0.000 description 1
206010060820 Joint injury Diseases 0.000 description 1
206010023509 Kyphosis Diseases 0.000 description 1
208000007623 Lordosis Diseases 0.000 description 1
206010031264 Osteonecrosis Diseases 0.000 description 1
208000006735 Periostitis Diseases 0.000 description 1
229920001283 Polyalkylene terephthalate Polymers 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
102000016611 Proteoglycans Human genes 0.000 description 1
108010067787 Proteoglycans Proteins 0.000 description 1
208000002607 Pseudarthrosis Diseases 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
208000020307 Spinal disease Diseases 0.000 description 1
229910001069 Ti alloy Inorganic materials 0.000 description 1
KJADKKWYZYXHBB-XBWDGYHZSA-N Topiramic acid Chemical compound C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 KJADKKWYZYXHBB-XBWDGYHZSA-N 0.000 description 1
230000009471 action Effects 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
239000000956 alloy Substances 0.000 description 1
229960000836 amitriptyline Drugs 0.000 description 1
KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 1
230000003466 anti-cipated effect Effects 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
230000001407 anti-thrombic effect Effects 0.000 description 1
229940125681 anticonvulsant agent Drugs 0.000 description 1
239000001961 anticonvulsive agent Substances 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
208000037873 arthrodesis Diseases 0.000 description 1
UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
229960002537 betamethasone Drugs 0.000 description 1
239000000560 biocompatible material Substances 0.000 description 1
239000003181 biological factor Substances 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
239000002639 bone cement Substances 0.000 description 1
238000009954 braiding Methods 0.000 description 1
229960003150 bupivacaine Drugs 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
229910010293 ceramic material Inorganic materials 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000000544 cholinesterase inhibitor Substances 0.000 description 1
229960002896 clonidine Drugs 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
238000009945 crocheting Methods 0.000 description 1
230000000991 decompressive effect Effects 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
208000018180 degenerative disc disease Diseases 0.000 description 1
230000002638 denervation Effects 0.000 description 1
239000000806 elastomer Substances 0.000 description 1
229960002464 fluoxetine Drugs 0.000 description 1
230000008014 freezing Effects 0.000 description 1
238000007710 freezing Methods 0.000 description 1
229960002870 gabapentin Drugs 0.000 description 1
239000003365 glass fiber Substances 0.000 description 1
229920002674 hyaluronan Polymers 0.000 description 1
229960003160 hyaluronic acid Drugs 0.000 description 1
230000001969 hypertrophic effect Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
208000014674 injury Diseases 0.000 description 1
208000021600 intervertebral disc degenerative disease Diseases 0.000 description 1
230000009545 invasion Effects 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
230000007794 irritation Effects 0.000 description 1
238000009940 knitting Methods 0.000 description 1
230000001050 lubricating effect Effects 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
239000012528 membrane Substances 0.000 description 1
239000007769 metal material Substances 0.000 description 1
229960005181 morphine Drugs 0.000 description 1
238000000465 moulding Methods 0.000 description 1
ALWKGYPQUAPLQC-UHFFFAOYSA-N neostigmine Chemical compound CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 ALWKGYPQUAPLQC-UHFFFAOYSA-N 0.000 description 1
229960002362 neostigmine Drugs 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
229940005483 opioid analgesics Drugs 0.000 description 1
201000008482 osteoarthritis Diseases 0.000 description 1
229940124641 pain reliever Drugs 0.000 description 1
239000002245 particle Substances 0.000 description 1
210000003460 periosteum Anatomy 0.000 description 1
229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920002620 polyvinyl fluoride Polymers 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000008439 repair process Effects 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
230000000452 restraining effect Effects 0.000 description 1
206010039722 scoliosis Diseases 0.000 description 1
230000007480 spreading Effects 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000000126 substance Substances 0.000 description 1
229920001059 synthetic polymer Polymers 0.000 description 1
210000004876 tela submucosa Anatomy 0.000 description 1
229960002372 tetracaine Drugs 0.000 description 1
GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
238000003856 thermoforming Methods 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
229960004394 topiramate Drugs 0.000 description 1
229960004380 tramadol Drugs 0.000 description 1
TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 description 1
230000008733 trauma Effects 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
230000035899 viability Effects 0.000 description 1
239000002699 waste material Substances 0.000 description 1
238000009941 weaving Methods 0.000 description 1
BPKIMPVREBSLAJ-QTBYCLKRSA-N ziconotide Chemical compound C([C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]2C(=O)N[C@@H]3C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CSSC2)C(N)=O)=O)CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSSC3)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(N1)=O)CCSC)[C@@H](C)O)C1=CC=C(O)C=C1 BPKIMPVREBSLAJ-QTBYCLKRSA-N 0.000 description 1
229960002811 ziconotide Drugs 0.000 description 1

Landscapes

Prostheses (AREA)

CA002566645A 2004-05-20 2005-05-18 Prothese d'unite rachidienne fonctionnelle Abandoned CA2566645A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US10/850,280 US20050055096A1 (en)	2002-12-31	2004-05-20	Functional spinal unit prosthetic
US10/850,280		2004-05-20
PCT/US2005/017346 WO2005112835A2 (fr)	2002-12-31	2005-05-18	Prothèse d'unité rachidienne fonctionnelle

Publications (1)

Publication Number	Publication Date
CA2566645A1 true CA2566645A1 (fr)	2005-12-01

Family

ID=37500244

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002566645A Abandoned CA2566645A1 (fr)	2004-05-20	2005-05-18	Prothese d'unite rachidienne fonctionnelle

Country Status (4)

Country	Link
EP (1)	EP1748747A2 (fr)
JP (1)	JP2007537834A (fr)
AU (1)	AU2005244913A1 (fr)
CA (1)	CA2566645A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2182864B1 (fr) *	2007-06-22	2016-06-08	Empirical Spine, Inc.	Dispositifs pour restreindre de façon contrôlée la flexion de segments rachidiens
EP2346425A4 (fr) *	2008-11-12	2012-04-18	Simpirica Spine Inc	Appareil de contrainte modulée et procédés d'utilisation
JP4995978B2 (ja) *	2011-03-15	2012-08-08	宏美林	人体を除く生体の治療方法

2005
- 2005-05-18 AU AU2005244913A patent/AU2005244913A1/en not_active Abandoned
- 2005-05-18 JP JP2007527400A patent/JP2007537834A/ja active Pending
- 2005-05-18 CA CA002566645A patent/CA2566645A1/fr not_active Abandoned
- 2005-05-18 EP EP05748919A patent/EP1748747A2/fr not_active Withdrawn

Also Published As

Publication number	Publication date
EP1748747A2 (fr)	2007-02-07
AU2005244913A1 (en)	2005-12-01
JP2007537834A (ja)	2007-12-27

Legal Events

Date	Code	Title	Description
2006-11-14	EEER	Examination request
2010-05-18	FZDE	Discontinued

Publication	Publication Date	Title
US20050055096A1 (en)	2005-03-10	Functional spinal unit prosthetic
US7101398B2 (en)	2006-09-05	Prosthetic facet joint ligament
US20210000608A1 (en)	2021-01-07	Facet joint implant
EP1437101A2 (fr)	2004-07-14	Ligament prothétique pour les facettes articulaires
US8672973B2 (en)	2014-03-18	Facet replacement/spacing and flexible spinal stabilization
US10568664B2 (en)	2020-02-25	Flanged interbody fusion device
US9451997B2 (en)	2016-09-27	Facet device and method
US20070161994A1 (en)	2007-07-12	Hinged Polyaxial Screw and methods of use
US20070299445A1 (en)	2007-12-27	Spine treatment devices and methods
US20070288014A1 (en)	2007-12-13	Spine treatment devices and methods
US20080208260A1 (en)	2008-08-28	Spine treatment devices and methods
US20080021466A1 (en)	2008-01-24	Spine treatment devices and methods
KR20080059188A (ko)	2008-06-26	극간 척추 안정화 디바이스
US20120059422A1 (en)	2012-03-08	Methods for compression fracture treatment with spinous process fixation systems
CA2566645A1 (fr)	2005-12-01	Prothese d'unite rachidienne fonctionnelle